Form 8-K - Current report:
SEC Accession No. 0001628280-17-000232
Filing Date
2017-01-13
Accepted
2017-01-13 17:00:50
Documents
4
Period of Report
2017-01-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K - TOTECT AGREEMENT a8k-totectagreement.htm 8-K 21265
2 EXHIBIT 99.1 TOTACT PRESS RELEASE a8ktotectpressrelease.htm EX-99.1 20147
3 clinigena02.jpg GRAPHIC 12175
4 cumberland.gif GRAPHIC 10657
  Complete submission text file 0001628280-17-000232.txt   74092
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 17528485
SIC: 2834 Pharmaceutical Preparations